These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24275769)
1. Aldosterone's mechanism of action: roles of lysine-specific demethylase 1, caveolin and striatin. Baudrand R; Pojoga LH; Romero JR; Williams GH Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):32-7. PubMed ID: 24275769 [TBL] [Abstract][Full Text] [Related]
2. Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action. Coutinho P; Vega C; Pojoga LH; Rivera A; Prado GN; Yao TM; Adler G; Torres-Grajales M; Maldonado ER; Ramos-Rivera A; Williams JS; Williams G; Romero JR Endocrinology; 2014 Jun; 155(6):2233-43. PubMed ID: 24654783 [TBL] [Abstract][Full Text] [Related]
3. Aldosterone Rapidly Enhances Levels of the Striatin and Caveolin-1 Proteins in Rat Kidney: The Role of the Mineralocorticoid Receptor. Inthachart K; Manotham K; Eiam-Ong S; Eiam-Ong S Endocrinol Metab (Seoul); 2019 Sep; 34(3):291-301. PubMed ID: 31565882 [TBL] [Abstract][Full Text] [Related]
4. Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production. Huang Y; Ting PY; Yao TM; Homma T; Brooks D; Katayama Rangel I; Adler GK; Romero JR; Williams JS; Pojoga LH; Williams GH J Endocrinol; 2019 Feb; 240(2):111-122. PubMed ID: 30400034 [TBL] [Abstract][Full Text] [Related]
5. Striatin heterozygous mice are more sensitive to aldosterone-induced injury. Garza AE; Trefts E; Katayama Rangel IA; Brooks D; Baudrand R; Moize B; Romero JR; Ranjit S; Treesaranuwattana T; Yao TM; Adler GK; Pojoga LH; Williams GH J Endocrinol; 2020 Jun; 245(3):439-450. PubMed ID: 32229698 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935 [TBL] [Abstract][Full Text] [Related]
7. Striatin, a calmodulin-dependent scaffolding protein, directly binds caveolin-1. Gaillard S; Bartoli M; Castets F; Monneron A FEBS Lett; 2001 Nov; 508(1):49-52. PubMed ID: 11707266 [TBL] [Abstract][Full Text] [Related]
8. Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans. Garza AE; Rariy CM; Sun B; Williams J; Lasky-Su J; Baudrand R; Yao T; Moize B; Hafiz WM; Romero JR; Adler GK; Ferri C; Hopkins PN; Pojoga LH; Williams GH Hypertension; 2015 Jan; 65(1):211-217. PubMed ID: 25368024 [TBL] [Abstract][Full Text] [Related]
9. Lysine-Specific Demethylase-1 Deficiency Increases Agonist Signaling Via the Mineralocorticoid Receptor. Treesaranuwattana T; Wong KYH; Brooks DL; Tay CS; Williams GH; Williams JS; Pojoga LH Hypertension; 2020 Apr; 75(4):1045-1053. PubMed ID: 32160100 [TBL] [Abstract][Full Text] [Related]
10. Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury. Ashton AW; Le TY; Gomez-Sanchez CE; Morel-Kopp MC; McWhinney B; Hudson A; Mihailidou AS Mol Endocrinol; 2015 Aug; 29(8):1144-55. PubMed ID: 26121234 [TBL] [Abstract][Full Text] [Related]
11. Activation of the mineralocorticoid receptor increases striatin levels. Pojoga LH; Coutinho P; Rivera A; Yao TM; Maldonado ER; Youte R; Adler GK; Williams J; Turchin A; Williams GH; Romero JR Am J Hypertens; 2012 Feb; 25(2):243-9. PubMed ID: 22089104 [TBL] [Abstract][Full Text] [Related]
12. Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor. Kohata N; Kurihara I; Yokota K; Kobayashi S; Murai-Takeda A; Mitsuishi Y; Nakamura T; Morisaki M; Kozuma T; Torimitsu T; Kawai M; Itoh H Hypertens Res; 2022 Apr; 45(4):641-649. PubMed ID: 35177789 [TBL] [Abstract][Full Text] [Related]
13. Evolving research in nongenomic actions of aldosterone. Williams JS Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):198-203. PubMed ID: 23519092 [TBL] [Abstract][Full Text] [Related]
14. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention. Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853 [TBL] [Abstract][Full Text] [Related]
15. Aldosterone and mineralocorticoid receptors in the cardiovascular system. Funder JW Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957 [TBL] [Abstract][Full Text] [Related]
16. Salt Sensitivity of Blood Pressure and Aldosterone: Interaction Between the Lysine-specific Demethylase 1 Gene, Sex, and Age. Parksook WW; Heydarpour M; Gholami SK; Luther JM; Hopkins PN; Pojoga LH; Williams JS J Clin Endocrinol Metab; 2022 Apr; 107(5):1294-1302. PubMed ID: 35022775 [TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs and the mineralocorticoid receptor in the kidney. Butterworth MB Mol Cell Endocrinol; 2021 Feb; 521():111115. PubMed ID: 33301840 [TBL] [Abstract][Full Text] [Related]
18. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor. Ruhs S; Nolze A; Hübschmann R; Grossmann C J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113 [TBL] [Abstract][Full Text] [Related]
19. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects. Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022 [TBL] [Abstract][Full Text] [Related]
20. Aldosterone receptor antagonists: current perspectives and therapies. Guichard JL; Clark D; Calhoun DA; Ahmed MI Vasc Health Risk Manag; 2013; 9():321-31. PubMed ID: 23836977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]